Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for cannabinoid therapy. Several research groups found anti-tumor properties of cannabinoids in vitro and in vivo studies.

Leukemia

leukemia cancers usually begin in the bone marrow and involves abnormal white blood cell production.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

PTSD

Posttraumatic stress disorder is considered a mental disorder caused after traumatic experiences like traffic accidents, violent circumstances, rape, warfare, etc. Typical symptoms include anxiety, nightmares, flashbacks and trauma-related cues.

Epilepsy

cannabinoids have excellent therapeutic potential for the treatment of epilepsy. In the brain, the endocannabinoid system tends to keep neuronal activity wihtin acceptable boundaries.

Psychosis and Schizophrenia

schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

ADHD

ADHD is a neurodevelopmental disorder that is characterised by loss of attention and impulsive behaviour.

Pain

pain is a very good target for therapeutic cannabinoids.

DHEA

Docosahexaenoylethanolamine is an endocannabinoid that is synthesized from docosahexaenoic acid / DHA, the major omega-3 fatty acid in the brain.

Hemopressin

Hemopressin is a recently discovered endocannabinoid that acts as a CB1 inverse agonist (roughly meaning that it has the opposite action of THC at